Transfusion (Asare) Flashcards
Role of IgM in immunohemotology
- Against carbohydrate-based antigens
- naturally occuring
- cause of intravascular hemolysis via complement
- agglutinate at room temp w/o coombs reagent
- examples: ABO antibodies, cold agglutinins
role of IgG
- against protein-based antigens
- previous exposure: transfusion or pregnancy
- cause extravascular hemolysis via RES
- requires coombs reagent for agglutination
ex. Rh, Kell, duffy (non-ABO)
RBCs - Universal donor
Group O
RBCs - universal recipient
Group AB
plasma universal recipient
Group O
plasma universal donor
group AB
Rh antigen system
D antigen (Rh system)
Autosomal dominant
Rh positive (85%)
Rh negative (15%)
Highly Immunogenic
80% of healthy D negative individuals will make anti-D after one unit of Rh-positive blood
~20% in hospitalized patients
15% of Rh-negative women who give birth to an
Rh-positive fetus make anti-D
hemolytic disease of the newborn/fetus
hemolysis of renal red cells
- anemia
- extramedullary hematopoesis
- liver, spleen (large immature blood cells in circulation)
- incidence of hemolytic disease of newborn can be decreased by providing RHig to Rh negative mother during pregnancy and at the time of delivery
Hemolytic newborn disease steps
Step 1: Rh+ father
Step 2: Rh- mother carrying her first Rh+ fetus. Rh antigens from the developing fetus can enter the mother’s blood during delivery
Step 3: in response to the Rh fetal antigens, the mother will produce anti-Rh antibodies.
Step 4: in the woman gets pregnant with another Rh+ fetus, her anti Rh antibodies will cross the placenta and damage fetal red blood cells
Packed Red blood cells
Indications:
- restoration of red cell oxygen carrying compacity
- improve tissue oxygen delivery
- allevaiation of signs and symptoms of anemia
- HNT
- tachycardia
- dizziness
- dyspnea
- decreased tissue perfusion
- ischemia
- general guidelines
- maintain hb >7
- increased mortality when hb drops to < 5
- need to keep higher HCT in CAD, pulmonary disease hb >8
- important to maintain normovolemia even with acute blood loss
platelets
Risk of hemorrhage:
- <5,000-
- high risk of spontaneous hemorrhage
- 5,000- 10,000
- increased risk of spontaneous hemorrhage
- high risk with trauma, invasive procedures, or ulceration
- 10000- 50,000
- variable risk with trauma
- >50,000
- bleeding from platelet deficiency uncommon
contraindication for platelet transfusion
thrombotic thrombocytopenia (TTP)
heparin induced thrombocytopenia (HIT)
immune mediated thrombocytopenia purport (ITP)
Transfusion criteria for FFP
diffuse microvascular bleeding
massive transfusion of more than one blood volume
warfarin overdose with major bleeding or impending surgery
PT > 1.5 x normal in non-bleeding pt scheduled for surgery or invasive procedure
treatment of coagulation pathway defect where specific factor concentrate is unavailable
plasma exchange in TTP or aHUS
Acute Hemolytic Reaction- clinical features
Fever, chills, pain at infusion site
- usually within first 15 minutes of transfusion
flank pain, chest pain, SOB
hemoglobinuria
hemoglobinemia
DIC
shock and cardiovascular collapse
warning: symptoms may be mind and non-specific intially (uneasiness, feeling of impending doom )
Acute Hemolytic reaction - management
STOP transfusion
send implicated blood bag to blood bank and draw new sample
Direct coombs test
blood sample from a pt with immune mediated hemolytic anemia: antibodies are shown attached to antigens on the RBC surface
The pt’s washed RBS are incubated with Antiguan antibodies
RBCs agglutinate: antihuman antibodies form links between RBCs by binding to the human antibodies on the RBCs.